Concepedia

Publication | Closed Access

A phase III trial of muparfostat (PI-88) as adjuvant therapy in patients with hepatitis virus related hepatocellular carcinoma (HV-HCC) after resection

34

Citations

0

References

2017

Year

No additional data available for this publication yet. Check back later!